Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.28e-05	28	141	4	GO:0001972
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-04	35	141	4	GO:0015020
GeneOntologyMolecularFunction	copper ion binding	CP F5 F8 HEPH LOXL2	2.28e-04	78	141	5	GO:0005507
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	2.94e-04	4	141	2	GO:0005219
GeneOntologyMolecularFunction	retinoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.64e-04	48	141	4	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.94e-04	49	141	4	GO:0019840
GeneOntologyMolecularFunction	ferroxidase activity	CP HEPH	7.29e-04	6	141	2	GO:0004322
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	7.29e-04	6	141	2	GO:0048763
GeneOntologyMolecularFunction	oxidoreductase activity, acting on metal ions, oxygen as acceptor	CP HEPH	7.29e-04	6	141	2	GO:0016724
GeneOntologyBiologicalProcess	estrogen catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.07e-08	5	142	4	GO:0006711
GeneOntologyBiologicalProcess	phenylpropanoid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0046271
GeneOntologyBiologicalProcess	coumarin catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0046226
GeneOntologyBiologicalProcess	flavone metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0051552
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-07	10	142	4	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-07	10	142	4	GO:0009804
GeneOntologyBiologicalProcess	flavonoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.47e-06	13	142	4	GO:0009812
GeneOntologyBiologicalProcess	flavonoid glucuronidation	UGT1A8 UGT1A7 UGT1A9	3.16e-06	5	142	3	GO:0052696
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.18e-05	21	142	4	GO:0052695
GeneOntologyBiologicalProcess	hormone catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.18e-05	21	142	4	GO:0042447
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.86e-05	26	142	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.86e-05	26	142	4	GO:0006063
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT1A8 UGT1A7 UGT1A9	6.72e-05	12	142	3	GO:0052697
GeneOntologyBiologicalProcess	steroid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.50e-05	34	142	4	GO:0006706
GeneOntologyBiologicalProcess	motor neuron migration	RELN CELSR3 CELSR2	1.37e-04	15	142	3	GO:0097475
Domain	Cu-oxidase_3	CP F5 F8 HEPH	1.46e-08	5	139	4	IPR011707
Domain	MULTICOPPER_OXIDASE1	CP F5 F8 HEPH	1.46e-08	5	139	4	PS00079
Domain	Cu_oxidase_CS	CP F5 F8 HEPH	1.46e-08	5	139	4	IPR033138
Domain	Cu-oxidase_3	CP F5 F8 HEPH	1.46e-08	5	139	4	PF07732
Domain	Cu_oxidase_Cu_BS	CP F5 F8 HEPH	4.36e-08	6	139	4	IPR002355
Domain	Cu-oxidase	CP F8 HEPH	4.03e-07	3	139	3	PF00394
Domain	Cu-oxidase	CP F8 HEPH	4.03e-07	3	139	3	IPR001117
Domain	Cu-oxidase_2	CP F8 HEPH	1.60e-06	4	139	3	IPR011706
Domain	SCD	STAG1 STAG3L3 STAG3	1.60e-06	4	139	3	PS51425
Domain	SCD	STAG1 STAG3L3 STAG3	1.60e-06	4	139	3	IPR020839
Domain	Cu-oxidase_2	CP F8 HEPH	1.60e-06	4	139	3	PF07731
Domain	-	CP F5 F8 HEPH	2.78e-06	14	139	4	2.60.40.420
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	PF00201
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	PS00375
Domain	UDP_glucos_trans	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	IPR002213
Domain	Cupredoxin	CP F5 F8 HEPH	1.94e-05	22	139	4	IPR008972
Domain	Factor_5/8	F5 F8	5.50e-05	2	139	2	IPR024715
Domain	MULTICOPPER_OXIDASE2	CP HEPH	1.64e-04	3	139	2	PS00080
Domain	Ryanodine_rcpt	RYR2 RYR3	1.64e-04	3	139	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR2 RYR3	1.64e-04	3	139	2	IPR009460
Domain	RyR	RYR2 RYR3	1.64e-04	3	139	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	1.64e-04	3	139	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	1.64e-04	3	139	2	IPR013333
Domain	STAG	STAG1 STAG3	3.27e-04	4	139	2	PF08514
Domain	STAG	STAG1 STAG3	3.27e-04	4	139	2	IPR013721
Domain	WW	WWOX NEDD4 ARHGAP12 SMURF2	4.09e-04	47	139	4	PF00397
Domain	WW	WWOX NEDD4 ARHGAP12 SMURF2	4.43e-04	48	139	4	SM00456
Domain	HAT_MYST-type	KAT6A KAT8	5.42e-04	5	139	2	IPR002717
Domain	K_chnl_volt-dep_KCNQ_C	KCNQ4 KCNQ2	5.42e-04	5	139	2	IPR013821
Domain	MOZ_SAS	KAT6A KAT8	5.42e-04	5	139	2	PF01853
Domain	K_chnl_volt-dep_KCNQ	KCNQ4 KCNQ2	5.42e-04	5	139	2	IPR003937
Domain	YIPPEE	YPEL2 YPEL1	5.42e-04	5	139	2	PS51792
Domain	KCNQ_channel	KCNQ4 KCNQ2	5.42e-04	5	139	2	PF03520
Domain	MYST_HAT	KAT6A KAT8	5.42e-04	5	139	2	PS51726
Domain	WW_DOMAIN_1	WWOX NEDD4 ARHGAP12 SMURF2	5.60e-04	51	139	4	PS01159
Domain	WW_DOMAIN_2	WWOX NEDD4 ARHGAP12 SMURF2	5.60e-04	51	139	4	PS50020
Domain	WW_dom	WWOX NEDD4 ARHGAP12 SMURF2	6.03e-04	52	139	4	IPR001202
Domain	RIH_assoc-dom	RYR2 RYR3	8.09e-04	6	139	2	IPR013662
Domain	Ins145_P3_rec	RYR2 RYR3	8.09e-04	6	139	2	PF08709
Domain	RIH_assoc	RYR2 RYR3	8.09e-04	6	139	2	PF08454
Domain	RIH_dom	RYR2 RYR3	8.09e-04	6	139	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	8.09e-04	6	139	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	8.09e-04	6	139	2	IPR015925
Domain	-	RYR2 RYR3	8.09e-04	6	139	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	8.09e-04	6	139	2	PF01365
Domain	SANT	TRERF1 DMAP1 DNAJC1	1.15e-03	28	139	3	PS51293
Domain	EGF_LAM_2	NTNG1 CELSR3 CELSR2	1.41e-03	30	139	3	PS50027
Domain	EGF_LAM_1	NTNG1 CELSR3 CELSR2	1.41e-03	30	139	3	PS01248
Domain	Yippee/Mis18/Cereblon	YPEL2 YPEL1	1.50e-03	8	139	2	IPR004910
Domain	Yippee-Mis18	YPEL2 YPEL1	1.50e-03	8	139	2	PF03226
Domain	EGF	FRAS1 RELN NTNG1 ADAM32 CELSR3 CELSR2 LRP2	1.91e-03	235	139	7	SM00181
Domain	EF-hand_8	EFCAB6 SLC25A25 RYR2	2.04e-03	34	139	3	PF13833
Domain	EGF_Lam	NTNG1 CELSR3 CELSR2	2.22e-03	35	139	3	SM00180
Domain	Laminin_EGF	NTNG1 CELSR3 CELSR2	2.22e-03	35	139	3	PF00053
Domain	MIR	RYR2 RYR3	2.38e-03	10	139	2	PF02815
Domain	MIR_motif	RYR2 RYR3	2.38e-03	10	139	2	IPR016093
Domain	MIR	RYR2 RYR3	2.38e-03	10	139	2	PS50919
Domain	MIR	RYR2 RYR3	2.38e-03	10	139	2	SM00472
Domain	EGF-like_dom	FRAS1 RELN NTNG1 ADAM32 CELSR3 CELSR2 LRP2	2.65e-03	249	139	7	IPR000742
Domain	MYB_LIKE	TRERF1 DMAP1 DNAJC1	2.81e-03	38	139	3	PS50090
Domain	Laminin_EGF	NTNG1 CELSR3 CELSR2	2.81e-03	38	139	3	IPR002049
Domain	GAIN_dom_N	CELSR3 CELSR2	2.89e-03	11	139	2	IPR032471
Domain	GAIN	CELSR3 CELSR2	2.89e-03	11	139	2	PF16489
Domain	EGF_1	RELN FN1 NTNG1 ADAM32 CELSR3 CELSR2 LRP2	3.02e-03	255	139	7	PS00022
Domain	EGF-like_CS	RELN FN1 NTNG1 ADAM32 CELSR3 CELSR2 LRP2	3.43e-03	261	139	7	IPR013032
Domain	ARM-type_fold	IPO8 STAG1 APOB RYR3 STAG3L3 CTNND2 STAG3 TNPO3	3.91e-03	339	139	8	IPR016024
Domain	-	IGSF6 FN1 MYOM1 CEACAM4 PAPLN SEMA3D FNDC7 FCRL3 TRIM9 SIGIRR CEACAM16 FCRL5	3.99e-03	663	139	12	2.60.40.10
Domain	Kelch_2	RABEPK KLHDC4	4.06e-03	13	139	2	IPR011498
Domain	Kelch_2	RABEPK KLHDC4	4.06e-03	13	139	2	PF07646
Domain	-	MRC1 FN1	4.06e-03	13	139	2	2.10.10.10
Domain	FN_type2_col-bd	MRC1 FN1	4.72e-03	14	139	2	IPR000562
Domain	FN2_2	MRC1 FN1	4.72e-03	14	139	2	PS51092
Domain	FN2_1	MRC1 FN1	4.72e-03	14	139	2	PS00023
Domain	fn2	MRC1 FN1	4.72e-03	14	139	2	PF00040
Domain	FN2	MRC1 FN1	4.72e-03	14	139	2	SM00059
Domain	CAP	GLIPR1 GLIPR1L2	5.42e-03	15	139	2	PF00188
Domain	SCP	GLIPR1 GLIPR1L2	5.42e-03	15	139	2	SM00198
Domain	Allrgn_V5/Tpx1	GLIPR1 GLIPR1L2	5.42e-03	15	139	2	IPR001283
Domain	-	GLIPR1 GLIPR1L2	5.42e-03	15	139	2	3.40.33.10
Domain	CAP_domain	GLIPR1 GLIPR1L2	5.42e-03	15	139	2	IPR014044
Domain	-	RABEPK KLHDC10 KLHDC4	5.46e-03	48	139	3	2.120.10.80
Domain	ConA-like_dom	RYR2 RYR3 CELSR3 CELSR2 TRIM9 SEL1L3	5.99e-03	219	139	6	IPR013320
Domain	SANT	TRERF1 DMAP1 DNAJC1	6.12e-03	50	139	3	SM00717
Domain	Ig-like_fold	IGSF6 FN1 MYOM1 CEACAM4 PAPLN SEMA3D FNDC7 FCRL3 TRIM9 SIGIRR CEACAM16 FCRL5	6.52e-03	706	139	12	IPR013783
Domain	SANT/Myb	TRERF1 DMAP1 DNAJC1	6.83e-03	52	139	3	IPR001005
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CP	9.94e-06	41	100	5	M7399
Pathway	WP_ESTROGEN_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.58e-05	22	100	4	MM15888
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.27e-05	24	100	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.69e-05	25	100	4	M17787
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.69e-05	25	100	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.69e-05	25	100	4	M605
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.16e-05	26	100	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.28e-05	28	100	4	M19580
Pathway	WP_CODEINE_AND_MORPHINE_METABOLISM	UGT1A10 UGT1A8 UGT1A9	1.19e-04	14	100	3	M39328
Pathway	REACTOME_PARACETAMOL_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.62e-04	39	100	4	MM15695
Pathway	REACTOME_ASPIRIN_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.84e-04	45	100	4	MM15694
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.61e-04	51	100	4	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.97e-04	52	100	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.16e-04	55	100	4	M14933
Pubmed	STAG3, a novel gene encoding a protein involved in meiotic chromosome pairing and location of STAG3-related genes flanking the Williams-Beuren syndrome deletion.	STAG3L1 STAG3L2 STAG3L3 STAG3	1.57e-09	5	148	4	10698974
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9 USP40	2.53e-09	14	148	5	21646302
Pubmed	Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.69e-09	6	148	4	32527940
Pubmed	Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.69e-09	6	148	4	20297805
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.09e-08	7	148	4	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.09e-08	7	148	4	8464825
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.09e-08	7	148	4	27514509
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.17e-08	8	148	4	20610558
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.17e-08	8	148	4	18052087
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.17e-08	8	148	4	17179145
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.90e-08	9	148	4	22511988
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1	5.19e-08	24	148	5	24625756
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.48e-08	10	148	4	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.48e-08	10	148	4	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.48e-08	10	148	4	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.48e-08	10	148	4	22558097
Pubmed	Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.	UGT1A10 UGT1A8 UGT1A9	7.55e-08	3	148	3	12847094
Pubmed	Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.	UGT1A10 UGT1A8 UGT1A9	7.55e-08	3	148	3	29519853
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.52e-07	12	148	4	20308471
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.52e-07	12	148	4	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.52e-07	12	148	4	11434514
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.18e-07	13	148	4	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.18e-07	13	148	4	25246029
Pubmed	Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A16 and 28.	UGT1A10 UGT1A7 UGT1A9	3.01e-07	4	148	3	17558305
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.05e-07	14	148	4	10836148
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.05e-07	14	148	4	9295054
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.05e-07	14	148	4	14672974
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.51e-07	16	148	4	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.18e-07	17	148	4	20639394
Pubmed	Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.	UGT1A8 UGT1A7 UGT1A9	7.50e-07	5	148	3	20565459
Pubmed	Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.	UGT1A10 UGT1A8 UGT1A9	7.50e-07	5	148	3	15057901
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.20e-07	18	148	4	20056724
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.16e-06	19	148	4	23281178
Pubmed	Discovery and refinement of loci associated with lipid levels.	FN1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB CPS1 CELSR2	3.66e-06	211	148	8	24097068
Pubmed	Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups.	TRGV1 TRGV3 TRGV8	4.16e-06	8	148	3	2938743
Pubmed	Human metabolic individuality in biomedical and pharmaceutical research.	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1	4.57e-06	57	148	5	21886157
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 POLE ARHGAP26 KAT6A PAPLN EDC4 PTCH1 ADCY7 CELSR3 CELSR2 SGSM2 USP40 KCNQ2 C1orf50 SMURF2 TNPO3 ABCC10	5.17e-06	1105	148	17	35748872
Pubmed	Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.	UGT1A10 UGT1A8 UGT1A9	6.23e-06	9	148	3	20732626
Pubmed	Patched-1 proapoptotic activity is downregulated by modification of K1413 by the E3 ubiquitin-protein ligase Itchy homolog.	PTCH1 NEDD4 SMURF2	8.87e-06	10	148	3	25092867
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC15A2	9.45e-06	66	148	5	19898482
Pubmed	Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.	UGT1A8 UGT1A7 UGT1A9	1.22e-05	11	148	3	18695635
Pubmed	NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.	WWOX NEDD4 SMURF2	1.62e-05	12	148	3	24107629
Pubmed	Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.	F5 F8	1.80e-05	2	148	2	26599105
Pubmed	[Genetic testing and prenatal diagnosis for two families affected with Joubert syndrome].	AHI1 CPLANE1	1.80e-05	2	148	2	32335874
Pubmed	The molecular basis of factor V and VIII procofactor activation.	F5 F8	1.80e-05	2	148	2	19765210
Pubmed	Mercury metallation of the copper protein azurin and structural insight into possible heavy metal reactivity.	CP F8	1.80e-05	2	148	2	25265377
Pubmed	Deletion of hephaestin and ceruloplasmin induces a serious systemic iron deficiency and disrupts iron homeostasis.	CP HEPH	1.80e-05	2	148	2	30060949
Pubmed	Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.	F5 F8	1.80e-05	2	148	2	28057741
Pubmed	Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9.	CELSR3 CELSR2	1.80e-05	2	148	2	10790539
Pubmed	The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.	F5 F8	1.80e-05	2	148	2	15735794
Pubmed	Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium.	CP HEPH	1.80e-05	2	148	2	22342521
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	1.80e-05	2	148	2	8898078
Pubmed	cDNA cloning and genomic organization of the murine MRP7, a new ATP-binding cassette transporter.	IPO8 ABCC10	1.80e-05	2	148	2	11943485
Pubmed	Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.	F5 F8	1.80e-05	2	148	2	17287628
Pubmed	Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy.	AVIL KCNQ2	1.80e-05	2	148	2	36552832
Pubmed	Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.	UGT1A7 UGT1A9	1.80e-05	2	148	2	11677206
Pubmed	The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.	CP HEPH	1.80e-05	2	148	2	21051716
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	1.80e-05	2	148	2	14550562
Pubmed	Substrate clustering potently regulates the activity of WW-HECT domain-containing ubiquitin ligases.	NEDD4 SMURF2	1.80e-05	2	148	2	29463679
Pubmed	Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.	CP HEPH	1.80e-05	2	148	2	26303407
Pubmed	Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.	UGT1A10 UGT1A8	1.80e-05	2	148	2	10497143
Pubmed	Ablation of hephaestin and ceruloplasmin results in iron accumulation in adipocytes and type 2 diabetes.	CP HEPH	1.80e-05	2	148	2	29355933
Pubmed	A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.	MRC1 F8	1.80e-05	2	148	2	17502612
Pubmed	Hephaestin and ceruloplasmin facilitate iron metabolism in the mouse kidney.	CP HEPH	1.80e-05	2	148	2	27991585
Pubmed	Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.	UGT1A7 UGT1A9	1.80e-05	2	148	2	12944498
Pubmed	Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor.	APOB LRP2	1.80e-05	2	148	2	10330424
Pubmed	Activated protein C has a regulatory role in factor VIII function.	F5 F8	1.80e-05	2	148	2	33512448
Pubmed	Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.	F5 F8	1.80e-05	2	148	2	11091190
Pubmed	Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.	UGT1A7 UGT1A9	1.80e-05	2	148	2	17529886
Pubmed	Identification of 2 Potentially Relevant Gene Mutations Involved in Strabismus Using Whole-Exome Sequencing.	AHI1 NEB	1.80e-05	2	148	2	28391287
Pubmed	Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD.	CP HEPH	1.80e-05	2	148	2	18326691
Pubmed	Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain.	CP HEPH	1.80e-05	2	148	2	25788583
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	1.80e-05	2	148	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	1.80e-05	2	148	2	16678258
Pubmed	Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.	UGT1A10 UGT1A9	1.80e-05	2	148	2	25547628
Pubmed	Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.	FN1 LOXL2	1.80e-05	2	148	2	31759052
Pubmed	Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.	CP HEPH	1.80e-05	2	148	2	15365174
Pubmed	Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.	F5 F8	1.80e-05	2	148	2	22613792
Pubmed	Ceruloplasmin and hephaestin jointly protect the exocrine pancreas against oxidative damage by facilitating iron efflux.	CP HEPH	1.80e-05	2	148	2	29883959
Pubmed	Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.	UGT1A10 UGT1A8	1.80e-05	2	148	2	11901093
Pubmed	Tripeptidyl peptidase II regulates sperm function by modulating intracellular Ca(2+) stores via the ryanodine receptor.	TPP2 RYR3	1.80e-05	2	148	2	23818952
Pubmed	Genetic risk of FCRL3 and FCRL5 polymorphisms in children with asthma and allergic rhinitis in a Chinese Han population.	FCRL3 FCRL5	1.80e-05	2	148	2	30771554
Pubmed	Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.	UGT1A10 UGT1A9	1.80e-05	2	148	2	22031623
Pubmed	Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.	UGT1A8 UGT1A9	1.80e-05	2	148	2	18568343
Pubmed	Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.	UGT1A10 UGT1A8	1.80e-05	2	148	2	17603215
Pubmed	UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.	UGT1A7 UGT1A9	1.80e-05	2	148	2	15709193
Pubmed	Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.	UGT1A10 UGT1A8	1.80e-05	2	148	2	9647757
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	1.80e-05	2	148	2	14985349
Pubmed	How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?	UGT1A10 UGT1A9	1.80e-05	2	148	2	20089735
Pubmed	Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture.	CP HEPH	1.80e-05	2	148	2	17065470
Pubmed	Multi-copper ferroxidase deficiency leads to iron accumulation and oxidative damage in astrocytes and oligodendrocytes.	CP HEPH	1.80e-05	2	148	2	31263155
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CFAP251 MYOM1 F5 GGCX CELSR3 CTNND2 CPLANE1 DNAH9 FHIP2B	2.62e-05	361	148	9	26167880
Pubmed	The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.	FN1 APOB PTCH1	2.66e-05	14	148	3	22144466
Pubmed	Variable region genes in the human T-cell rearranging gamma (TRG) locus: V-J junction and homology with the mouse genes.	TRGV1 TRGV3 TRGV8	3.31e-05	15	148	3	2969332
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GLIPR1 DMXL2 RELN FN1 STAG1 TTLL5 RYR3 DMAP1 FRY CELSR3 TRIM9 SGSM2 NAV3 LRP2 KCNQ2 CTNND2 SMURF2	3.57e-05	1285	148	17	35914814
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	FN1 CP APOB LOXL2	3.74e-05	44	148	4	31273033
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	5.38e-05	3	148	2	18403125
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	5.38e-05	3	148	2	29730765
Pubmed	Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.	UGT1A7 UGT1A9	5.38e-05	3	148	2	16636344
Pubmed	Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.	UGT1A10 UGT1A9	5.38e-05	3	148	2	20007669
Cytoband	2q37	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.05e-06	31	148	4	2q37
Cytoband	12q21.2	GLIPR1 ZDHHC17 GLIPR1L2	3.59e-05	20	148	3	12q21.2
Cytoband	7p14	TRGV1 TRGV3 TRGV8	1.25e-04	30	148	3	7p14
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A10 UGT1A8 UGT1A7 UGT1A9 USP40	8.64e-04	226	148	5	chr2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr12q21	GLIPR1 ZDHHC17 NAV3 GLIPR1L2	1.16e-03	141	148	4	chr12q21
GeneFamily	UDP glucuronosyltransferases	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.49e-05	32	97	4	363
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	8.52e-05	3	97	2	913
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	8.52e-05	3	97	2	287
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	8.52e-05	3	97	2	1189
GeneFamily	T cell receptor gamma locus at 7p14	TRGV1 TRGV3 TRGV8	2.14e-04	22	97	3	375
GeneFamily	Yippee like family	YPEL2 YPEL1	2.82e-04	5	97	2	1130
GeneFamily	Cohesin complex	STAG1 STAG3	7.81e-04	8	97	2	1060
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 DMAP1 DNAJC1	2.89e-03	53	97	3	532
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A KAT8	3.26e-03	16	97	2	66
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT6A KAT8	3.68e-03	17	97	2	486
GeneFamily	Armadillo repeat containing\|Importins	IPO8 TNPO3	4.12e-03	18	97	2	596
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C FRAS1 RELN EFCAB6 APOB CPS1 NEB RYR2 RYR3 NAV3 LRP2 KCNQ2 DNAH9	5.04e-14	184	147	13	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C FRAS1 RELN EFCAB6 APOB CPS1 NEB RYR2 RYR3 NAV3 LRP2 KCNQ2 DNAH9	5.04e-14	184	147	13	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C FRAS1 RELN EFCAB6 APOB CPS1 NEB RYR2 RYR3 NAV3 LRP2 KCNQ2 DNAH9	5.04e-14	184	147	13	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP F8 SEMA3D CLCA2 LOXL2 NAV3	2.45e-07	191	147	8	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP F8 SEMA3D CLCA2 LOXL2 NAV3	2.45e-07	191	147	8	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN EFCAB6 NEB YPEL1 RYR3 TRIM9	1.01e-06	159	147	7	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN EFCAB6 NEB YPEL1 RYR3 TRIM9	1.01e-06	159	147	7	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 POLE CPS1 NEB F5 FRRS1L DNAH9	1.15e-06	162	147	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 MYOM1 RYR2 RYR3 LRP2 RPL13A DNAH9	1.52e-06	169	147	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	LIAS YPEL2 DRC1 NUDT12 NRSN2 FCRL3 SEL1L3	1.92e-06	175	147	7	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN CP F8 RYR3 SEMA3D CLCA2	1.92e-06	175	147	7	84d252f3e432231687613299bbea14978bb4b06b
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RYR2 KCNQ4 LRP2 FCRL5 RPL13A DNAH9	1.92e-06	175	147	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	P15-Endothelial-lymphatic_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN CP F8 RYR3 SEMA3D CLCA2	1.92e-06	175	147	7	a00c6fa9b33640710dd05a3799031147196f0986
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RYR2 KCNQ4 LRP2 FCRL5 RPL13A DNAH9	2.00e-06	176	147	7	c6484334187f64cd00cd35e77d8ae436556b4260
ToppCell	facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP F8 SEMA3D CLCA2 NAV3	2.00e-06	176	147	7	057d2759fdc67176c25802b57a78064d8cc93205
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP F8 SEMA3D CLCA2 NAV3	2.00e-06	176	147	7	b81e5d23b31cefc8d374ef403e21acc390c14a80
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2 NAV3	2.50e-06	182	147	7	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2 NAV3	2.50e-06	182	147	7	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2 NAV3	2.50e-06	182	147	7	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP F8 SEMA3D CLCA2 LOXL2 NAV3	3.32e-06	190	147	7	e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP F8 SEMA3D CLCA2 LOXL2 NAV3	3.32e-06	190	147	7	f32d66c0e74e0a2a23ecb857c4daf0d8573a806c
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP F8 SEMA3D CLCA2 LOXL2 NAV3	3.32e-06	190	147	7	b79ffd05806244a9790cd04c66fb4f92c824e69f
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP SEMA3D CLCA2 NAV3 ZMYND12	3.32e-06	190	147	7	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP SEMA3D CLCA2 NAV3 ZMYND12	3.32e-06	190	147	7	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP SEMA3D CLCA2 NAV3 ZMYND12	3.32e-06	190	147	7	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 PTCH1 SEMA3D TMEM47 LOXL2 ANTXR1 CTNND2	3.68e-06	193	147	7	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OGFRL1 NTNG1 CP CELSR2 CLCA2 SLC15A2 MMP15	3.80e-06	194	147	7	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLIPR1 OGFRL1 CHRNA6 IGSF6 CEACAM4 TLR1 SYK	3.80e-06	194	147	7	024568d8a862f0fe4da1f66a58c6e71f0e8279f3
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GLIPR1 MRC1 OGFRL1 IGSF6 CEACAM4 SYK CLNK	4.21e-06	197	147	7	4f7c10a636646dfc82a84026c1b5a36603367abe
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GLIPR1 MRC1 OGFRL1 IGSF6 CEACAM4 SYK CLNK	4.35e-06	198	147	7	da36c1bb62fdd1da7aca9c5115432a87fb48adb0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PAPLN GRM3 HEPH RYR3 FNDC7 TMEM47 SLC15A2	4.65e-06	200	147	7	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C DRC1 PTCH1 LOXL2 ALOXE3	1.51e-05	94	147	5	d25f096626af873f724a8cd6454ed56e33fd9854
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C DRC1 PTCH1 LOXL2 ALOXE3	1.51e-05	94	147	5	2fb80a08f823295fa4c3e6494bf020e5b4052f0f
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 CPS1 RYR2 RYR3 LRP2 DNAH9	1.54e-05	160	147	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 CPS1 RYR2 RYR3 LRP2 DNAH9	1.54e-05	160	147	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MYOM1 SLCO3A1 HEPH FRY TRIM9	1.59e-05	161	147	6	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 FRY TLR1 SYK PLEKHM3 CLNK	1.90e-05	166	147	6	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	E16.5-Endothelial-Endothelial_lymphatic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 RELN SLCO3A1 F8 SEMA3D CLCA2	1.96e-05	167	147	6	b93103a868fba63a8910bffb690a6242b9252833
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 RELN SLCO3A1 F8 SEMA3D CLCA2	1.96e-05	167	147	6	fcd583b1efd0ac883379982ea8e6c54f2c0be268
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 RELN SLCO3A1 F8 SEMA3D CLCA2	1.96e-05	167	147	6	f6bc63138b7239211fa5f27a8dc799b6e022c0f8
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 RELN SLCO3A1 F8 SEMA3D CLCA2	1.96e-05	167	147	6	26cd8ee5e826e71eaf58d10a906543a6932fb3f9
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	MRC1 DMXL2 MYOM1 RYR2 SYK CTNND2	2.17e-05	170	147	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 MYOM1 SLCO3A1 GRM3 HEPH TRIM9	2.17e-05	170	147	6	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 MYOM1 SLCO3A1 GRM3 HEPH TRIM9	2.17e-05	170	147	6	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	droplet-Lung-nan-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLIPR1 OGFRL1 IGSF6 FN1 ARHGAP26 PNP	2.32e-05	172	147	6	35d09640d5b04fa0bbb1b40d4b8f97da587a5046
ToppCell	droplet-Spleen-nan-21m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLIPR1 FRAS1 UBL5 SYK FCRL5 RPL13A	2.32e-05	172	147	6	3dc02709c2a6be2155576e5c34e1b0b3ae19b061
ToppCell	droplet-Lung-nan-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLIPR1 OGFRL1 IGSF6 FN1 ARHGAP26 PNP	2.32e-05	172	147	6	98cb64e2a768908105701a7a5b58f336036250fd
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	MRC1 RELN FN1 CP SEMA3D SEL1L3	2.32e-05	172	147	6	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN FN1 ARHGAP26 F8 NEDD4 SEMA3D	2.32e-05	172	147	6	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 FN1 SLCO3A1 TMEM47 ANTXR1 STAG3	2.55e-05	175	147	6	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP RYR3 SEMA3D CLCA2	2.55e-05	175	147	6	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 CFAP251 ARHGAP26 SLCO3A1 DRC1 SEL1L3	2.55e-05	175	147	6	284fdc7a9d303636a637041846850d19d114861a
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN CP RYR3 SEMA3D CLCA2	2.55e-05	175	147	6	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	Dendritic_Cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	TRERF1 OGFRL1 CHRNA6 ADCY7 CTNND2 CLNK	2.72e-05	177	147	6	d2cd081bdda0eba9f6f6473c4d3939e4bee3440e
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN CP F8 SEMA3D CLCA2	2.72e-05	177	147	6	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN CP F8 SEMA3D CLCA2	2.72e-05	177	147	6	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FCRL3 SLC15A2 SEL1L3 SYK FCRL5 STAG3	2.81e-05	178	147	6	812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GLIPR1 MACC1 EFCAB6 NEB FNDC7	2.96e-05	108	147	5	514dfc3f7ac303311ae599f981f3f3c7eb6801b8
ToppCell	(5)_Epithelial_cells-(5)_Glands_mucous\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CP CPB1 NXPE2 F5 RYR2 SEL1L3	2.99e-05	180	147	6	a4118adaf4b09e2ca01b662ed60e7bbf32a24d58
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 PAPLN SEMA3D SGSM2 LOXL2 LRP2	3.08e-05	181	147	6	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 PAPLN SEMA3D SGSM2 LOXL2 LRP2	3.08e-05	181	147	6	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CFAP251 ARHGAP26 LRGUK TUBA4B DNAH9 ZMYND12	3.08e-05	181	147	6	51d91b923920463245e95d65c6a5197e21d34d73
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 FRAS1 ACVR1C RYR3 NRSN2 KCNQ2	3.18e-05	182	147	6	d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 FRAS1 ACVR1C RYR3 NRSN2 KCNQ2	3.18e-05	182	147	6	6cde859edfe7607bd7ada89d20258413d06f4207
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PTCH1 F8 RYR3 SEMA3D CLCA2	3.28e-05	183	147	6	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 PTCH1 SEMA3D TMEM47 LOXL2 ANTXR1	3.28e-05	183	147	6	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CP F8 SEMA3D CLCA2 NAV3	3.59e-05	186	147	6	f23f21781a758541f59c06efa7739d26a03fb478
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 ARHGAP26 PAPLN NEDD4 SEL1L3 LRP2	3.59e-05	186	147	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CP F8 SEMA3D CLCA2 NAV3	3.59e-05	186	147	6	0de87109da9324c597fadf2eb782f0f158afe832
ToppCell	severe_influenza-B_intermediate\|severe_influenza / disease group, cell group and cell class (v2)	NTNG1 MSMP FCRL3 SEL1L3 FCRL5 IGKV2-29	3.70e-05	187	147	6	d6db8595aa72fdabc4a056ba6ce09876868a66d5
ToppCell	(0)_Myeloid-(011)_pDC\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	MACC1 AHI1 PAPLN SEL1L3 FCRL5 MMP15	3.81e-05	188	147	6	a81b5d840490d6a636fe168f8cff2c4984369f09
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	3.81e-05	188	147	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CP F8 SEMA3D CLCA2 NAV3	3.81e-05	188	147	6	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	3.81e-05	188	147	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MACC1 ADCY7 FRY SEL1L3 SYK CTNND2	3.81e-05	188	147	6	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CP F8 SEMA3D CLCA2 NAV3	3.81e-05	188	147	6	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MACC1 ADCY7 FRY SEL1L3 LRP2 CTNND2	3.81e-05	188	147	6	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	3.93e-05	189	147	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MACC1 FRAS1 FRY SEL1L3 LRP2 CTNND2	3.93e-05	189	147	6	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	3.93e-05	189	147	6	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	3.93e-05	189	147	6	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MACC1 FRAS1 FRY SEL1L3 LRP2 CTNND2	4.04e-05	190	147	6	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	COVID_vent-Lymphocytic-B_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	FCRL3 SLC15A2 SEL1L3 SYK FCRL5 RPL13A	4.04e-05	190	147	6	40b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCell	COVID_vent-Lymphocytic-B_cell-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	FCRL3 SLC15A2 SEL1L3 SYK FCRL5 RPL13A	4.04e-05	190	147	6	a37a32dc1b931562a6660074e19d5598efc65284
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2	4.04e-05	190	147	6	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2	4.04e-05	190	147	6	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN CP F8 SEMA3D CLCA2	4.04e-05	190	147	6	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	CFAP251 CP DRC1 RYR3 TUBA4B DNAH9	4.16e-05	191	147	6	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FRAS1 RELN NTNG1 RYR2 SEMA3D NAV3	4.16e-05	191	147	6	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	4.16e-05	191	147	6	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP GGCX SEMA3D CLCA2 NAV3	4.16e-05	191	147	6	51cff0594ac7ad8c065c8ea2301f8c149bd062b4
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	4.16e-05	191	147	6	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP GGCX SEMA3D CLCA2 NAV3	4.16e-05	191	147	6	a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN CP GGCX SEMA3D CLCA2 NAV3	4.16e-05	191	147	6	38681a1b182d6af5cce85db5431b6eba4b20ad96
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	CFAP251 CP DRC1 RYR3 TUBA4B DNAH9	4.16e-05	191	147	6	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP251 EFCAB6 DRC1 LRGUK TUBA4B DNAH9	4.16e-05	191	147	6	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FN1 NTNG1 SLCO3A1 RYR2 SEMA3D ANTXR1	4.29e-05	192	147	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MACC1 FRAS1 ADCY7 FRY LRP2 CTNND2	4.29e-05	192	147	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 FRAS1 AHI1 FRY SYK PNP	4.29e-05	192	147	6	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	OGFRL1 CHRNA6 MACC1 FN1 ANTXR1 SMURF2	4.41e-05	193	147	6	198552810dcac8d0ca63a78badd6702b49ff6edf
Drug	lamotrigine	UGT1A10 UGT1A8 UGT1A7 UGT1A9 PTCH1 GRM3 RYR2 RYR3 LOXL2 CACNG4	3.44e-09	116	144	10	CID000003878
Drug	naringenin chalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.64e-09	5	144	4	ctd:C027329
Drug	anthrarobin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.64e-09	5	144	4	ctd:C032186
Drug	tritanol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 PNP	1.17e-08	13	144	5	CID000006457
Drug	1,2,5,8-tetrahydroxy anthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.28e-08	6	144	4	ctd:C543211
Drug	alloin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.28e-08	6	144	4	ctd:C006457
Drug	2',5'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.28e-08	6	144	4	ctd:C107497
Drug	DEPC	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9 XK SLC15A2	4.23e-08	53	144	7	CID000015357
Drug	2',4'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.29e-08	7	144	4	ctd:C059354
Drug	almokalant	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HEPH	1.02e-07	19	144	5	CID003033962
Drug	niflumic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CELSR3 CLCA2 KCNQ4 KCNQ2 PNP	1.03e-07	125	144	9	CID000004488
Drug	1,4-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-07	8	144	4	ctd:C034890
Drug	4'-hydroxydiclofenac	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.36e-07	20	144	5	CID000116545
Drug	AC1MRQNQ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.89e-07	9	144	4	CID003522271
Drug	DHPASiU	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.89e-07	9	144	4	CID000197602
Drug	3-iodophenol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.89e-07	9	144	4	CID000012272
Drug	2,3,2-tet	GABRQ CP APOB ARFRP1	1.89e-07	9	144	4	CID000078479
Drug	AC1L4J7U	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.89e-07	9	144	4	CID000186631
Drug	Chebi:32663	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.89e-07	9	144	4	CID005460873
Drug	amonafide	LIAS UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.28e-07	22	144	5	CID000050515
Drug	2,6-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.13e-07	10	144	4	ctd:C034889
Drug	propofol	CHRNA6 MACC1 UGT1A10 UGT1A8 UGT1A7 GABRQ UGT1A9 RYR2 RYR3 SIGIRR	3.96e-07	191	144	10	CID000004943
Drug	Hymecromone	FN1 UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.53e-07	25	144	5	ctd:D006923
Drug	4-nitrophenyl)imidazole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.89e-07	11	144	4	CID000123155
Drug	AC1O5XMV	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.89e-07	11	144	4	CID006442661
Drug	retigabine	UGT1A10 UGT1A8 UGT1A7 UGT1A9 KCNQ4 KCNQ2	5.68e-07	48	144	6	CID000121892
Drug	N-OH-DABZ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	CID000088735
Drug	4-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	ctd:C026418
Drug	Drotrecogin alfa	CP F5 F8 GGCX	7.30e-07	12	144	4	DB00055
Drug	2,4,6-TCB	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	CID000037247
Drug	nonanoyl-N-methylglucamide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.30e-07	12	144	4	CID000276709
Drug	Finrazole	FN1 UGT1A10 UGT1A8 UGT1A7 GABRQ UGT1A9	8.21e-07	51	144	6	CID000178036
Drug	erucin	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.25e-07	28	144	5	CID000078160
Drug	valproate	RELN UGT1A10 UGT1A8 UGT1A7 GABRQ UGT1A9 CPS1 PTCH1 RYR2 RYR3 KCNQ4 CACNG4 TUBA4B	9.60e-07	381	144	13	CID000003121
Drug	hydratropic acid	UGT1A10 UGT1A8 UGT1A7	9.87e-07	4	144	3	ctd:C013025
Drug	2-vanillin	UGT1A10 UGT1A8 UGT1A7	9.87e-07	4	144	3	ctd:C060843
Drug	diphenylacetic acid	UGT1A10 UGT1A8 UGT1A7	9.87e-07	4	144	3	ctd:C037760
Drug	2-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-06	13	144	4	ctd:C024980
Drug	5-azido-UDP-glucuronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-06	13	144	4	CID003081279
Drug	cotinine-N-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-06	13	144	4	CID000000411
Drug	alizarin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-06	13	144	4	ctd:C010078
Drug	tolcapone	UGT1A10 UGT1A8 UGT1A7 UGT1A9 LOXL2	1.18e-06	30	144	5	CID004659569
Drug	propranolol glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.46e-06	14	144	4	CID000119515
Drug	PCB-61	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.46e-06	14	144	4	CID000036401
Drug	Muracein C	UGT1A10 UGT1A8 UGT1A7 UGT1A9 NEDD4	1.66e-06	32	144	5	CID003086323
Drug	BP-3,6-quinol	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.94e-06	33	144	5	CID000119292
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	CID000040469
Drug	afloqualone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	CID000002040
Drug	naphthyl sulphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	CID000114775
Drug	coumarin-3-carboxylic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	CID000010752
Drug	bergamottin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	ctd:C068337
Drug	sulforaphane nitrile	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.98e-06	15	144	4	CID000543743
Drug	isovaleric acid	UGT1A10 UGT1A8 UGT1A7	2.45e-06	5	144	3	ctd:C008216
Drug	biphenylylacetic acid	UGT1A10 UGT1A8 UGT1A7	2.45e-06	5	144	3	ctd:C012776
Drug	diethylpyrocarbonate	ACP6 GNPDA1 WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC15A2 P4HA1	2.46e-06	182	144	9	CID000003051
Drug	quercetin-3,4'-diglucoside	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.63e-06	16	144	4	CID005320835
Drug	1'-hydroxyestragole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.63e-06	16	144	4	CID000040003
Drug	bilirubin-phosphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.63e-06	16	144	4	CID005497144
Drug	muraglitazar	UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB	3.04e-06	36	144	5	CID000206044
Drug	glucoraphanin	TRERF1 UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.04e-06	36	144	5	CID000656556
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.43e-06	17	144	4	CID000003573
Drug	6-hydroxychrysene	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.43e-06	17	144	4	CID000037766
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	OGFRL1 LIAS WWOX FN1 RYR2 SLC15A2 STAG3 ABCC10 FHIP2B	3.66e-06	191	144	9	5351_DN
Drug	x Me	UGT1A10 UGT1A8 UGT1A7 UGT1A9 NAA16	4.00e-06	38	144	5	CID009600424
Drug	acacetin	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.00e-06	38	144	5	CID005280442
Drug	SureCN12722713	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID005488034
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID000152226
Drug	Br 2	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID003060900
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID000036614
Drug	ApApG	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID003081975
Drug	C1 11-32	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID000443077
Drug	C11131	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-06	18	144	4	CID000443076
Drug	troglitazone; Up 200; 10uM; HL60; HT_HG-U133A	GLIPR1 CHRNA6 PTCH1 CELSR3 CELSR2 LRP2 DNAJC1 KLHDC10 FHIP2B	4.71e-06	197	144	9	1173_UP
Drug	3-phenylpropionic acid	UGT1A10 UGT1A8 UGT1A7	4.89e-06	6	144	3	ctd:C035253
Drug	Indoprofen	UGT1A10 UGT1A8 UGT1A7	4.89e-06	6	144	3	ctd:D007216
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	OGFRL1 PDE1C IPO8 ENPP4 NEB RYR2 NRSN2 CTNND2 MMP15	5.11e-06	199	144	9	7029_UP
Drug	9-OH-risperidone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.52e-06	19	144	4	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.52e-06	19	144	4	CID000091433
Drug	L 654969	UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB	6.65e-06	42	144	5	CID000005218
Drug	AC1NFJIQ	UGT1A10 UGT1A8 UGT1A7 UGT1A9 LOXL2	6.65e-06	42	144	5	CID004659568
Drug	5-hydroxytryptophol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 LOXL2	6.65e-06	42	144	5	CID000009061
Drug	tectochrysin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.87e-06	20	144	4	CID005281954
Drug	AC1L1OBF	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.87e-06	20	144	4	CID000032736
Drug	entacapone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.87e-06	20	144	4	ctd:C071192
Drug	androsterone glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB	7.49e-06	43	144	5	CID000114833
Drug	anthraflavic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB	8.40e-06	44	144	5	CID000006776
Drug	estriol-16-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.45e-06	21	144	4	CID000122281
Drug	dulcin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.45e-06	21	144	4	CID000009013
Drug	Benzamidoxime hydrochloride	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.45e-06	21	144	4	CID000069186
Drug	N-benzylformamide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 F5 F8	8.76e-06	76	144	6	CID000080654
Drug	mercury	ACP6 FN1 GABRQ CPB1 F5 HEPH GGCX RYR2 RYR3 TLR1 NAV3 CACNG4 TUBA4B ABCC10	9.21e-06	542	144	14	CID000023931
Drug	8-azaguanine	WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9 PNP	1.02e-05	78	144	6	CID000008646
Drug	AC1N8H7N	IPO8 UGT1A10 UGT1A8 UGT1A7 UGT1A9 TNPO3	1.02e-05	78	144	6	CID004318740
Drug	N-methylpiperazine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.03e-05	22	144	4	CID000053167
Drug	plumbagin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.03e-05	22	144	4	ctd:C014758
Drug	amidoxime	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.24e-05	23	144	4	CID000465967
Drug	estradiol-3-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.24e-05	23	144	4	CID000066651
Drug	phenanthridine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.24e-05	23	144	4	CID000009189
Disease	X-21448 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9 USP40	5.73e-10	10	141	5	EFO_0800816
Disease	N-acetyl-4-chlorophenylalanine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.49e-09	5	141	4	EFO_0801060
Disease	5-hydroxyindole sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.49e-09	5	141	4	EFO_0800085
Disease	nuclear receptor subfamily 1 group D member 2 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.49e-09	5	141	4	EFO_0801853
Disease	X-21339 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-08	7	141	4	EFO_0800808
Disease	X-11793--oxidized bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0021260
Disease	Succinimide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0022118
Disease	X-11530 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0800696
Disease	X-10458 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0800692
Disease	X-24849 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0800909
Disease	serum N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0600043
Disease	plasma clozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0600038
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0802740
Disease	X-16946 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-08	8	141	4	EFO_0800766
Disease	X-11442 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0021236
Disease	X-11441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0801036
Disease	X-11880 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.18e-08	9	141	4	EFO_0004570, GO_0009410
Disease	bilirubin measurement, response to tenofovir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.03e-07	10	141	4	EFO_0004570, EFO_0009279
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.03e-07	10	141	4	EFO_0802185
Disease	X-23974 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.03e-07	10	141	4	EFO_0800867
Disease	indole-3-carboxylate measurement	UGT1A10 UGT1A8 UGT1A9	1.07e-07	3	141	3	EFO_0800043
Disease	blood 4-oxo-retinoic acid measurement	UGT1A10 UGT1A8 UGT1A9	1.07e-07	3	141	3	EFO_0022216
Disease	pregnenetriol sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0600039
Disease	histidine betaine (hercynine) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0800972
Disease	X-21796 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-07	11	141	4	EFO_0010219
Disease	p-cresol glucuronide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-07	12	141	4	EFO_0800079
Disease	biliverdin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.40e-07	12	141	4	EFO_0021033
Disease	pregnenetriol disulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-07	13	141	4	EFO_0800587
Disease	retinol dehydrogenase 16 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.45e-07	13	141	4	EFO_0802007
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.13e-06	17	141	4	EFO_0004611, EFO_0007800
Disease	X-21441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.13e-06	17	141	4	EFO_0800814
Disease	angiopoietin-related protein 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.45e-06	18	141	4	EFO_0801382
Disease	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	UGT1A10 UGT1A8 UGT1A9	2.11e-06	6	141	3	EFO_0800566
Disease	tissue factor measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.81e-06	21	141	4	EFO_0010623
Disease	cholelithiasis	LIAS UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1	4.20e-06	88	141	6	EFO_0004799
Disease	neuroblastoma, cutaneous melanoma	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.36e-06	28	141	4	EFO_0000389, EFO_0000621
Disease	xanthurenate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.08e-05	29	141	4	EFO_0010551
Disease	response to dolutegravir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.24e-05	30	141	4	EFO_0600017
Disease	indoleacetate measurement	UGT1A10 UGT1A8 UGT1A9	1.25e-05	10	141	3	EFO_0021015
Disease	gallstones	LIAS UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1	1.37e-05	108	141	6	EFO_0004210
Disease	vitamin D deficiency	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.92e-05	37	141	4	EFO_0003762
Disease	X-24588 measurement	UGT1A10 UGT1A8 UGT1A9	2.95e-05	13	141	3	EFO_0800898
Disease	urate measurement, bone density	GLIPR1 FRAS1 WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9 LOXL2 USP40 GLIPR1L2 CTNND2 DNAH9	4.46e-05	619	141	12	EFO_0003923, EFO_0004531
Disease	hormone measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9 RYR2	5.29e-05	84	141	5	EFO_0004730
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	6.78e-05	3	141	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	6.78e-05	3	141	2	DOID:8545 (implicated_via_orthology)
Disease	vitamin D measurement, COVID-19	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.96e-05	49	141	4	EFO_0004631, MONDO_0100096
Disease	urate measurement, spine bone mineral density	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-04	58	141	4	EFO_0004531, EFO_0007701
Disease	JOUBERT SYNDROME 17	AHI1 CPLANE1	2.25e-04	5	141	2	C3553264
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	STAG1 ARHGAP26 APOB CELSR2	2.39e-04	63	141	4	EFO_0001645, EFO_0004792
Disease	bilirubin measurement	STAG1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB CPS1 ACVR1C USP40	2.87e-04	442	141	9	EFO_0004570
Disease	anorexia nervosa	WWOX NTNG1 CELSR3 LRP2	3.59e-04	70	141	4	MONDO_0005351
Disease	metabolite measurement	CFAP251 WWOX UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1 AACS KYAT3 PNP	3.75e-04	560	141	10	EFO_0004725
Disease	tissue plasminogen activator measurement, coronary artery disease	STAG1 ARHGAP26 APOB CELSR2	3.79e-04	71	141	4	EFO_0001645, EFO_0004791
Disease	Hirschsprung Disease	RELN SEMA3D CELSR3	4.35e-04	31	141	3	C0019569
Disease	LDL cholesterol change measurement	APOB CELSR2	4.69e-04	7	141	2	EFO_0007804
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	6.23e-04	8	141	2	EFO_0008589, EFO_0008595
Disease	thyroxine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.85e-04	83	141	4	EFO_0005130
Disease	liver fibrosis measurement	MRC1 CFAP251 APOB CELSR2	7.83e-04	86	141	4	EFO_0010576
Disease	infant white matter volume measurement	WWOX MYOM1	7.98e-04	9	141	2	EFO_0008370
Disease	high density lipoprotein cholesterol measurement, multiple sclerosis	SLC15A2 SYK	9.95e-04	10	141	2	EFO_0004612, MONDO_0005301
Disease	long QT syndrome (implicated_via_orthology)	KCNQ4 KCNQ2	9.95e-04	10	141	2	DOID:2843 (implicated_via_orthology)
Disease	Schizophrenia	RELN AHI1 NTNG1 GABRQ CP GRM3 ADCY7 SEMA3D KAT8 LRP2 KCNQ2 CTNND2	1.12e-03	883	141	12	C0036341
Disease	vitamin D measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9 APOB CPS1 CELSR2	1.20e-03	336	141	7	EFO_0004631
Disease	cigarettes per day measurement	RABEPK CHRNA6 PDE1C WWOX STAG1 ARHGAP26 SGSM2 MED27	1.26e-03	438	141	8	EFO_0006525
Disease	apolipoprotein B measurement	FN1 STAG1 UGT1A10 UGT1A8 UGT1A7 ZFP28 UGT1A9 APOB ACVR1C CELSR2	1.36e-03	663	141	10	EFO_0004615
Disease	dodecanedioate measurement	UGT1A10 UGT1A8	1.45e-03	12	141	2	EFO_0021054
Disease	gallbladder carcinoma (is_marker_for)	PTCH1 ANTXR1	1.45e-03	12	141	2	DOID:4948 (is_marker_for)
Disease	susceptibility to measles measurement	YPEL2 NUDT12 CTNND2	1.68e-03	49	141	3	EFO_0008414
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	KCNQ4 KCNQ2	1.71e-03	13	141	2	DOID:0112202 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	TRERF1 WWOX FN1 UGT1A9 NEDD4 IGBP1 FCRL3 ARFRP1 CLCA2 LOXL2 FCRL5 KLHDC10 DNAH9	1.97e-03	1074	141	13	C0006142
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	1.99e-03	14	141	2	EFO_0004611, EFO_0008589
Disease	glucose metabolism measurement, age-related hearing impairment	WWOX TRIM9 NAV3	1.99e-03	52	141	3	EFO_0005782, EFO_0009367
Disease	pathological myopia	NAV3 CTNND2 CLNK DNAH9	2.01e-03	111	141	4	EFO_0004207
Disease	coronary artery disease, factor VII measurement	STAG1 ARHGAP26 APOB CELSR2	2.01e-03	111	141	4	EFO_0001645, EFO_0004619
Disease	factor VIII measurement, coronary artery disease	STAG1 ARHGAP26 APOB CELSR2	2.15e-03	113	141	4	EFO_0001645, EFO_0004630
Disease	triglycerides in medium HDL measurement	STAG1 APOB CELSR2	2.22e-03	54	141	3	EFO_0022321
Disease	Hypertriglyceridemia	APOB CELSR2	2.29e-03	15	141	2	C0020557
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	2.29e-03	15	141	2	EFO_0007804, GO_0036273
Disease	von Willebrand factor measurement, coronary artery disease	STAG1 ARHGAP26 APOB CELSR2	2.52e-03	118	141	4	EFO_0001645, EFO_0004629
Disease	Hypertrophic Cardiomyopathy	MYOM1 RYR2 KAT8	2.59e-03	57	141	3	C0007194
Disease	Blood Coagulation Disorders	F5 GGCX	2.60e-03	16	141	2	C0005779
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	2.94e-03	17	141	2	EFO_0022232
Disease	docosahexaenoic acid measurement	APOB CELSR2 DNAJC1 CTNND2	3.28e-03	127	141	4	EFO_0007761
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	APOB CELSR2	3.30e-03	18	141	2	EFO_0008317, EFO_0008589
Disease	calcium measurement	CPS1 HEPH DMAP1 CELSR2 SLC15A2 USP40 DNAJC1 ABCC10 FHIP2B	3.30e-03	628	141	9	EFO_0004838
Disease	limited scleroderma	TLR1 TNPO3	3.68e-03	19	141	2	EFO_1001017
Disease	sodium-coupled monocarboxylate transporter 1 measurement	APOB CELSR2	3.68e-03	19	141	2	EFO_0802076

Protein segments in the cluster

Peptide	Gene	Start	Entry
TNHWKYIAYSDGASI	ARSK	421	Q6UWY0
RTQAEHYLWYGKGSS	AVIL	546	O75366
CNISETIQAYYWHKG	CEACAM4	56	O75871
TIQAYYWHKGKTAEG	CEACAM4	61	O75871
KSGSVLHHWNEIYYF	ANTXR1	51	Q9H6X2
GLALESYDDLYHWSV	AACS	41	Q86V21
IIYDLSWSKDDHYIL	AHI1	656	Q8N157
VHGLSGELLAYSWYA	CEACAM16	41	Q2WEN9
GKYSYLKVGHWAETL	GRM3	476	Q14832
LWLVSEYHEQGSLYD	ACVR1C	266	Q8NER5
HIVVDKTLYDYWGSD	ADAM32	191	Q8TC27
DGTFLVWHVKYLDEY	DMXL2	516	Q8TDJ6
GVSDGQWHTVQLKYY	CELSR2	1446	Q9HCU4
FIGDKLNEDWYHQSY	ADCY7	861	P51828
ADSDHLTIYNAYLGW	DHX29	1131	Q7Z478
SHAASYTWKYEGKNL	CYB5D1	171	Q6P9G0
HYAVVWSIYLEKQLD	DNAJC1	166	Q96KC8
DLRSLYKKDGWSQYH	CTNND2	1021	Q9UQB3
YDHTLSIVNWYSHLK	CFAP251	526	Q8TBY9
YQYHTEEQHWTLLKF	RABEPK	271	Q7Z6M1
VLATASHDGYVKFWQ	EDC4	311	Q6P2E9
SHDGYVKFWQIYIEG	EDC4	316	Q6P2E9
SQSLLHSDGKTYLYW	IGKV2D-29	46	A0A075B6S2
EKHYYIGIIETTWDY	CP	21	P00450
GAVALHVYQAYWKAV	ABCC10	866	Q5T3U5
GDYEKLEHNHTYIQW	OGFRL1	146	Q5TC84
VDALYKVEAGHQWYL	FRAS1	3806	Q86XX4
GHYTQVVWADSYKVG	GLIPR1	136	P48060
HADIWVKSYSLYSRE	IL15RA	41	Q13261
DWREHTKYKNGYSAN	NEDD4	1206	P46934
LEHYSQASEWAAKYI	GNPDA1	6	P46926
SNYIQLVWDHSYKVG	GLIPR1L2	156	Q4G1C9
TLWQLVEHYSYKADG	SYK	236	P43405
EAGTLYTIKAYAWNA	FNDC7	171	Q5VTL7
HQTWKDSRLAYYETT	GABRQ	111	Q9UN88
KIHIGNYEIDAWYFS	KAT8	181	Q9H7Z6
YHYRDDGLKIWAAIE	ALOXE3	506	Q9BYJ1
FSIQNYTEKLGWYHS	MMP15	146	P51511
VYAHSKELITAWYIG	KCNQ4	231	P56696
LWGLYESIQDYKHLC	FAM89B	111	Q8N5H3
KHSEGRVEVYYDGQW	LOXL2	66	Q9Y4K0
ILYWFYHEDVTLGSS	FCRL5	596	Q96RD9
YWFYHEDVTLGKISA	FCRL5	691	Q96RD9
FVEHWKGITHYYIES	FHIP2B	26	Q86V87
TVSDWYEQHRKYGAL	IGBP1	266	P78318
WTAYSLNKIHAYNLE	KLHDC10	281	Q6PID8
YAHSKELVTAWYIGF	KCNQ2	226	O43526
HYLLYKTGVANWLTE	PDE1C	241	Q14123
VYKEHAQEVYSVDWS	PEX7	106	O00628
WIGYAIAYHLLKDYD	NAA16	151	Q6N069
KIYTDWANHYLAKSG	NAV3	81	Q8IVL0
VSWLEFIYSKDYQLH	CSNKA2IP	681	A0A1B0GTH6
ATLYWEEPDASGHKY	ENPP4	181	Q9Y6X5
YNTAKAIAEWGLDYV	LIAS	161	O43766
HEVAYWYILSIGAQT	F8	651	P00451
TIDYTNDLLYWADAH	LRP2	3371	P98164
GLHYYTTLEELWKSF	LRGUK	701	Q96M69
GWVKEITQYHNIYAD	POLE	1801	Q07864
YKWSNKLQYHAGLAS	MED27	111	Q6P2C8
SVEDGKWYGVRSYLH	NRSN2	16	Q9GZP1
GYLEIRKDHDSYWQS	PLEKHM3	216	Q6ZWE6
LWDALYTALEKYHLV	DRC1	676	Q96MC2
LLHYSYDNGITWKLL	RELN	796	P78509
YDNGITWKLLEHYSY	RELN	801	P78509
GHTLYTSDYTNEKWL	ARHGAP12	351	Q8IWW6
AKYVHGIAVHWYLDF	GBA	341	P04062
VHYRISKSAWLSGYE	P4HA1	376	P13674
VIEFGKYEIHTWYSS	KAT6A	511	Q92794
WEIIDASGYKHDIKY	CHRNA6	206	Q15825
ELQSLWDKYYAECHG	ARFRP1	81	Q13795
AYGSTVSKRVAWHYD	APOB	1156	P04114
LYDYVNKYHWEHTGL	APOB	4081	P04114
LLVLDYSKDYNHWLA	CPS1	131	P31327
YSKDYNHWLATKSLG	CPS1	136	P31327
WYLEVDYTHEAVTIK	IGSF6	36	O95976
IAIGTDYWLYSSAHI	CACNG4	26	Q9UBN1
IHYWDIRYKQDVGHL	CPLANE1	646	Q9H799
LWARYDTEGKGHITY	EFCAB6	891	Q5THR3
QEYQLYLHDDAWTKA	DMAP1	141	Q9NPF5
SLDGYFHLWKAENTL	DCAF12	271	Q5T6F0
QIGDSWEKYVHGVRY	FN1	571	P02751
ETIVDLHLSWYYLFA	FRRS1L	216	Q9P0K9
LRYLYSQKESGHSNW	ATL3	81	Q6DD88
VYDWKVLADVLGYSH	MACC1	661	Q6ZN28
LAQGDTYWYHDEKLL	FCRL3	51	Q96P31
GEQFYHYKDLWVLHL	KLHDC4	146	Q8TBB5
SQSLLHSDGKTYLYW	IGKV2-29	46	A2NJV5
EHTAYIWDYFISKTE	FAM172BP	211	A6NC97
QHLDYGHWYDRSKLS	DNAH9	2566	Q9NYC9
WYKRQNGIEDESHEY	FRY	131	Q5TBA9
WLIYSKFKATYDGNH	KDELR1	76	P24390
SDGQWHTVHLRYYNK	CELSR3	1596	Q9NYQ7
YAYRLGHILNSWKEQ	CST9L	66	Q9H4G1
YTEHSVQEKNWYSLV	SLC15A2	476	Q16348
LQGYEKSWIETEEHY	RYR2	3621	Q92736
TYEDYKNTAEWLLSH	PNP	6	P00491
ATGHSYEKYNKWETI	CPB1	111	P15086
AYKLQHDLSWTPYED	C1orf50	151	Q9BV19
DEVYEWLVYSGNKHL	KYAT3	246	Q6YP21
HWPGVVDKIDYYLQS	IPO8	126	O15397
VYLDLDGYWKTAHCN	MRC1	1191	P22897
VWGHYDLCKTQIYTE	NTNG1	26	Q9Y2I2
GELYVVHHLWAYKDL	NIPSNAP1	226	Q9BPW8
LEGSWHEALLYYVLA	SEL1L3	886	Q68CR1
ASTLYIHWYLHQEGK	TRGV1	46	A0A0A0MS02
HQYKYEAGEIRWGAE	SLCO3A1	131	Q9UIG8
KSYTIHYSEQGVEWK	F5	2151	P12259
DSTLHQWIYYLQKAV	NXPE2	366	Q96DL1
WHNQSEKDSYGYIFL	HEPH	756	Q9BQS7
YLYVQEKRHFGTSWV	ARHGAP26	271	Q9UNA1
FKGYEYVSHINWNED	PTCH1	376	Q13635
LEYTKLKTADHYWTD	SGSM2	181	O43147
HYSLHEYSWVKANLS	SIGIRR	61	Q6IA17
TNTFYIHWYLHQEGK	TRGV3	46	P03979
TALDIAVFWGYKHIA	NUDT12	81	Q9BQG2
YYSWGEELTETQHMI	SKIV2L	811	Q15477
LTDSYLKYIGWTLHD	STAG3L1	41	P0CL83
ISYSGHDSFWVKNEL	TLR1	641	Q15399
HYIRTDISEHYWLNG	SEMA3D	226	O95025
NYAWGHYTIGKEFID	TUBA4B	41	Q9H853
RKDVQHNEWYIGEYS	CLNK	301	Q7Z7G1
YEKANVIVTDWYGAH	CLCA2	106	Q9UQC9
LYWKHSTIFDVGENL	SLC25A25	156	Q6KCM7
VYETLKNAWLQHYAV	SLC25A25	356	Q6KCM7
WNQHYDLYIGKSDSV	SMURF2	61	Q9HAU4
LGWKYEHAFESSQKY	YPEL1	86	O60688
TSYNLEYSLLGEHWD	ZFP28	206	Q8NHY6
LLDKTSWNNHSYLYG	GGCX	151	P38435
HDLTWYQYHSLDVIG	UGT1A10	476	Q9HAW8
CHYEGKYFTLGESWL	MSMP	46	Q1L6U9
TDSYLKYIGWTLHDK	STAG3	341	Q9UJ98
AYLGRLAHEVGWKYQ	RPL13A	136	P40429
KNVRGEYYLNGHWTI	PAPLN	226	O95428
GWVTPDYHLYSEKFD	RYR3	1346	Q15413
WYYSGKDIIDESGQH	RYR3	3786	Q15413
KWYTIFKDHVSLGDY	UBL5	46	Q9BZL1
KCDLVNYSYGEATHW	TPP2	321	P29144
KYLASLGNWTYKAHV	ZNF840P	76	A6NDX5
TTKDGWVYYANHTEE	WWOX	26	Q9NZC7
LTDSYLKYIGWTLHD	STAG3L2	41	P0CL84
FLNDSYLKYVGWTLH	STAG1	326	Q8WVM7
YLKYVGWTLHDRQGE	STAG1	331	Q8WVM7
VSLKIYHEFNWGYGL	TMEM47	141	Q9BQJ4
HLESKEWFVQLYYHG	ACP6	366	Q9NPH0
HDLTWYQYHSLDVIG	UGT1A9	476	O60656
ISYWGLHCETTYTKD	ZDHHC17	501	Q8IUH5
LYTKVSEIWHAYLNN	ZMYND12	236	Q9H0C1
KGIHYWELTVDRYDN	TRIM9	576	Q9C026
WYRLGEHLYKTNDEV	TNPO3	346	Q9Y5L0
LGWKYEHAFESSQKY	YPEL2	86	Q96QA6
ENAVYTHWYLHQEGK	TRGV8	46	A0A0C4DH27
LTDSYLKYIGWTLHD	STAG3L3	41	P0CL85
EISRSTYYAWKHELL	VRTN	341	Q9H8Y1
YHVYIKDVDHLGNWQ	USP40	306	Q9NVE5
DLISKSHNWYQLLVY	XK	306	P51811
HDLTWYQYHSLDVIG	UGT1A7	476	Q9HAW7
TWEIYGSYLEHKTSM	TTLL5	491	Q6EMB2
HDLTWYQYHSLDVIG	UGT1A8	476	Q9HAW9
NYHYAGSDKWTSLER	TRERF1	881	Q96PN7
VTYYVEDLKVNWSHN	MYOM1	1481	P52179
VSDVDYKNYLHQWTC	NEB	2376	P20929
LVSDVDYKNYLHQWT	NEB	2861	P20929